TMDA | Tanzania Medicines & Medical Devices Authority Home

First slide [1024x605]

"Together we protect and promote public health"

First slide [1024x605]

"When you sensitize a woman, the whole society is sensitized"

First slide [1024x605]

A group photo between TMDA and TBS management teams during the meeting to discuss the regulation of tobacco products held on 3rd February, 2021 at TBS Conference hall in DSM

First slide [1024x605]

Director General of TMDA, Mr. Adam Fimbo delivering his opening remarks to officiate the stakeholders meeting to discuss the Tanzania Medicines and Medical Devices (Good Storage and Distribution Practices) Draft Regulations held at TMDA conferences hall Dar es Salaam on 28th January, 2021

First slide [1024x605]

TMDA Director General, Mr. Adam Fimbo (seated centre) in a group photo with stakeholders in a meeting to discuss the Tanzania Medicines and Medical Devices (Good Storage and Distribution Practices) Draft Regulations held at TMDA conferences hall Dar es Salaam on 28th January, 2021

First slide [1024x605]

TMDA Customer Service coordinator from TMDA Sub Office Dsm, Ms Roberta Feruzi elaborates a point to Authority staff dealing with customer service during the special training aiming to improve clients' services held on 27th - 29th January, 2021 at Kibaha, Coast Region

First slide [1024x605]

A group photo between TMDA Director General, Mr. Adam Fimbo (seated centre) and staff dealing with customer service during the special training aiming to improve clients' services held on 27th - 29th January, 2021 at Kibaha, Coast Region

First slide [1024x605]

A group photo of stakeholders who participated in a meeting to discuss Regulation of Tobacco products held on 26th January, 2021 at TMDA Conference Hall in Dar es Salaam

First slide [1024x605]

TMDA Director General, Mr. Adam Fimbo, presenting an opening remarks during the stakeholders’ meeting to discuss Regulation of Tobacco products held on 26th January, 2021 at TMDA Conference Hall in Dar es Salaam

First slide [1024x605]

TMDA implements the preventive Plan Maintenance to all its laboratory plants and equipment. The above pictures show laboratory equipment engineers from Chemetrix Ltd of South Africa performing services to TMDA lab equipment based in Dar es Salaam and Mwanza. The maintenance services were performed mid-January 2021

First slide [1024x605]

Draft regulations of the Tanzania Medicines and Medical Devices (Good Storage and Distribution Practices) Regulations, 2021 for comments by stakeholders.

First slide [1024x605]

The Ministerial Advisory Board (MAB) in one of their ordinary meeting to discuss various regulatory issues. The meeting was held on 10th December, 2020 at TMDA offices in Dar es Salaam.

First slide [1024x605]

The Ministerial Advisory Board (MAB) in one of their ordinary meeting to discuss various regulatory issues. The meeting was held on 10th December, 2020 at TMDA offices in Dar es Salaam.

First slide [1024x605]

TMDA participated in 5th Tanzanian Industrial Products Exhibitions which took place from 3rd December, 2020 to 9th December, 2020 at Mwl J. K Nyerere Trade Fair Ground, Kilwa Road, Dar es Salaam.

First slide [1024x605]

TMDA Director General Mr. Adam Fimbo (seated centre) together with Director of Busines Support, Mr. Chrispin Severe and Dr. Diana Mwiru from University of Dar es Salaam Business School in a group photo with data enumerators during the special training on how to conduct a Service Delivery Survey to TMDA's clients. The SDS kick off meeting was held in Dar es Salaam on 8th December, 2020.

First slide [1024x605]

Chief Medical Officer, Dr. Abel Makubi, officiate the kickoff meeting for the ASCEND Project which aimed at moving Tanzania’s Clinical Research Ethics and Medicines Regulatory capacity to the next level by fostering medicine quality, safety and GCP on clinical trials. The meeting was held on 26th November 2020 in Dar salaam. Other institutions that will collaborate to implement the ASCEND project which take 30 months includes NIMR, KCRI, MUHAS, ZFDA, ZAHRI and St. Andrew’s University of UK.

First slide [1024x605]

Chief Medical Officer, Dr. Abel Makubi, officiate the kickoff meeting for the ASCEND Project which aimed at moving Tanzania’s Clinical Research Ethics and Medicines Regulatory capacity to the next level by fostering medicine quality, safety and GCP on clinical trials. The meeting was held on 26th November 2020 in Dar salaam. Other institutions that will collaborate to implement the ASCEND project which take 30 months includes NIMR, KCRI, MUHAS, ZFDA, ZAHRI and St. Andrew’s University of UK.

First slide [1024x605]

Drug Inspector, Dr. Daniel Fussy receiving a certificate from TMDA Director General (center), Mr. Adam Mitangu Fimbo during a closing ceremony of the training on Medicines Evaluation and Registration which was held from 16th – 20th November, 2020 at SoP-MUHAS

First slide [1024x605]

TMDA Acting Manager, Medicines Registration, Mr. Felchism Apolnary presenting a topic on medicines evaluation during the training conducted by the Regional Centre of Regulatory Excellence (RCORE) in Medicines Evaluation and Registration that was held from 16th – 20th November, 2020 at MUHAS in DSM

First slide [1024x605]

Tanga Regional Commissioner, Hon. Martine Shigela presenting his speech to officiate the training of the Medicines Inspectors from Tanga region. The training was held from 09th to 13th November, 2020.

First slide [1024x605]

Tanga Regional Commissioner, Hon. Martine Shigela in a group photo with TMDA officials immediately after gracing the training for Medicines Inspectors from Tanga region. The training was held from 09th to 13th November, 2020 in Tanga city.

First slide [1024x605]

TMDA Eastern Zone Manager, Mr. Adonis Bitegeko, presenting a topic on code of ethics to inspectors during the training conducted by TMDA to Medicines Inspectors from Tanga region that was held from 09th to 13th November, 2020.

First slide [1024x605]

First slide [1024x605]

First slide [1024x605]

A group photo of participants in the training on Active Toxicity Monitoring of Adverse Drug Reactions associated with the use of Dolutegravir (DTG), a recently introduced Anti-Retroviral Therapy (ART) for People Living with HIV/AIDS. The training which was held from 28th-29th September, 2020 took place at TMDA Conference Hall comprises representatives of healthcare providers from 21 Care and Treatment Centres (CTC) from 8 regions of Tanzania.

Latest News

More News

Online Service Icon

Online Service

Registered Product Icon

Registered Products

TMDA Guidelines Icon

TMDA Guidelines

Customer Feedback Icon

Customer Feedback

Online Support

Toll free Services: 0800 110 084
Medicine Registration: medicines@tmda.go.tz
Clinical Trials: clinicaltrials@tmda.go.tz
Medical Devices and IVD: medicaldevices@tmda.go.tz
Import and Export, GMP: enforcement@tmda.go.tz

View More

Latest News

05^th Feb, 2021

Guidelines on Submission of Documentation for Renewal of Marketing Authorization of Human and Veterinary Medicinal Products

03^th Feb, 2021

Extension for payment of annual retention fees for the year 2021 to 28th February with no retention fee penalties

15^th Jan, 2021

Invitation for Comments on a Draft of The Tanzania Medicines and Medical Devices (Good Storage and Distribution Practices) Regulations, 2021

10^th Dec, 2020

Ufafanuzi Kuhusu Ulipaji wa Malipo kwa Ajili ya Tafiti za Majaribio ya Dawa Zinazofanywa na Wanafunzi wa Vyuo vya Elimu ya Juu

10^th Dec, 2020

Clarification on Fees and Charges for Academic Research

30^th Nov, 2020

Online System for Submission of Applications for Withdrawal of Marketing Authorizations of Medicinal Products and Change of Local Technical Representa